Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Cagliari, Idenix Cayman LtdfiledCriticalUniv Cagliari
Publication of UY26735A1publicationCriticalpatent/UY26735A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Un método y una composición para el tratamiento de un sujeto infectado con Flavivirus o Pestivirus que comprende administrar una cantidad eficaz para el tratamiento de Flavivirus o Pestivirus de un pentofuranonucleósido modificado en 1', 2' o 3' o una sal aceptable para uso farmacéutico o prodroga del mismo.A method and composition for the treatment of a Flavivirus or Pestivirus infected subject comprising administering an effective amount for the treatment of Flavivirus or Pestivirus of a 1 ', 2' or 3 'modified pentofuranonucleoside or a salt acceptable for pharmaceutical use or prodrug of the same.
UY26735A2000-04-112001-05-28
METHODS AND COMPOSITIONS FOR TREATING FLAVIVIRUS AND PESTIVIRUS
UY26735A1
(en)
a compound or a pharmaceutically acceptable salt or ester thereof, a method for treating or prophylaxis a host infected with a flavivirus, pestivirus or hepacivirus infection, and a pharmaceutical composition for treating a host infected with a flavivirus, pestivirus or hepacivirus
Use of escitalopram or a pharmaceutically acceptable salt thereof to prepare a medicament useful in the treatment of post-traumatic stress disorder (divisional sol. 1799-00).
PHARMACEUTICAL COMPOSITION THAT INCLUDES A COMPOUND DERIVED FROM 1,4-DIPIPERIDIN-4-IL-PIPERAZINA; AND ITS USE FOR THE PREVENTION AND / OR TREATMENT OF PAIN.